Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Channel Type
3.3. Snippet by System
3.4. Snippet by Application
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising research and development activities related to ion channel modulators
4.1.1.2. Rising prevalence of chronic conditions
4.1.2. Restraints
4.1.2.1. High cost associated with drug discovery
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Ion Channel Opener*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Ion Channel Blocker
8. By Channel Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Channel Type
8.1.2. Market Attractiveness Index, By Channel Type
8.2. Ligand Gated Ion Channels*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Voltage-Gated Ion Channels
8.4. Sodium Channel
8.5. Potassium Channel
8.6. Calcium Channel
8.7. Chloride Channel
8.8. Others
9. By System
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By System
9.1.2. Market Attractiveness Index, By System
9.2. Cardiovascular*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Nervous System
9.4. Endocrine System
9.5. Gastro-Intestinal System
9.6. Others
10. By Application
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Therapeutic*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Research
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Pfizer Inc.
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Novartis AG
12.3. Zydus Pharmaceuticals, Inc.
12.4. Teva Pharmaceuticals USA, Inc.
12.5. Azurity Pharmaceuticals, Inc.
12.6. Sanofi
12.7. Sun Pharmaceutical Industries Ltd.
12.8. Bausch Health Companies Inc.
12.9. Cipla Inc.
12.10. Aspen Pharmacure Australia Pty Ltd
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us